APM
EBS icon

Avidity Partners Management’s Emergent Biosolutions EBS Stock Holding History

Avidity Partners Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,908,000
Closed -$4.83M – 95
2024
Q1 		$4.83M Buy
+1,908,000
New +$4.3M 0.16% 78

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Avidity Partners Management's EBS Position: Q2 2024 in Review

Avidity Partners Management sold out of Emergent Biosolutions (EBS) in Q2 2024, closing a stake of 1,908,000 shares — an estimated $4.83M sold.

Avidity Partners Management first reported a position in EBS in Q1 2024 and held it in 1 quarter. The position peaked at $4.83M in Q1 2024. 141 funds tracked by Wall St. Rank hold EBS as of Q2 2024.

  • Avidity Partners Management reported no remaining Emergent Biosolutions position as of Q2 2024 after selling out during the quarter.
  • Avidity Partners Management sold 1,908,000 Emergent Biosolutions shares in Q2 2024, an estimated $4.83M.
  • Avidity Partners Management first reported a position in Emergent Biosolutions in Q1 2024 and held it in 1 quarter.
  • Avidity Partners Management's Emergent Biosolutions position peaked at $4.83M in Q1 2024.
  • 141 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2024.

Based on Avidity Partners Management's 13F filing for Q2 2024, filed 14 Aug 2024.